Abstract
1.1. Introduction: Kinetic Oscillation Stimulation (KOS) is a new treatment for symptoms of non-allergic rhinitis (NAR). The aim of the study was to investigate effectiveness of KOS treatment in patients affected by NAR. 1.2. Methods: From December 2018 to July 2020, 39 patients, already refractory to conventional medical therapy, were treated with KOS. As control group, we considered a group of 41 patients treated with topical mometasone furoate, observed in the same period and number of days. During the ENT visit, objective examinations were performed to assess respiratory function. In addition, all the subjects filled out quality of life (QoL) questionnaires. All patients were reevaluated after 45 days. 1.3. Results: All the instrumental assessments and QoL questionnaires showed a significant improvement 45 days after KOS treatment. Sixteen patients (43%) reported an improvement across all tests. Active anterior rhinomanometry improved for Inspiratory Resistance in 26 patients (70%) and for Expiratory Resistance for 27 patients (73%). Moreover, we found that KOS group presented a better improvement statistically significant for the QoL questionnaries, respect the control group. 1.4. Conclusion: KOS treatment is a safe and mini-invasive procedure for the treatment of NAR symptoms, well accepted from patients and with a promising improvement of QoL, better than conventional medical therapies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: American Journal of Surgery and Clinical Case Reports
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.